Literature DB >> 9223664

Chromosomal translocations deregulating c-myc are associated with normal immune responses.

V Roschke1, E Kopantzev, M Dertzbaugh, S Rudikoff.   

Abstract

Plasmacytomas induced in BALB/c mice by pristane consistently evidence chromosomal translocations involving the c-myc gene and one of the Ig loci. This observation has lead to the suggestion that c-myc deregulation is a critical event in the generation of such tumors. However, it is not clear whether c-myc translocation is related to pristane treatment or occurs in normal lymphocyte populations nor whether such translocations occur normally, and at similar frequencies, in strains genetically resistant to plasmacytoma development, such as DBA/2. In order to address these questions, a Long Distance PCR assay with single copy sensitivity was employed to assess the frequency of c-myc/IgA translocations in normal and immunized mice of both plasmacytoma resistant and susceptible lineages in the absence of pristane treatment. Our data demonstrate that spontaneous translocations occur in normal DBA/2 and BALB/c mice with no significant differences in frequency. A 3-5-fold increase in translocation frequency was observed in mice immunized with cholera toxin, a strong stimulator of IgA responses. We conclude that c-myc deregulation by chromosomal translocation is associated with normal physiological processes of B-cell differentiation and, as such, can not be the determining factor leading to malignancy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223664     DOI: 10.1038/sj.onc.1201156

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Role of genomic instability and p53 in AID-induced c-myc-Igh translocations.

Authors:  Almudena R Ramiro; Mila Jankovic; Elsa Callen; Simone Difilippantonio; Hua-Tang Chen; Kevin M McBride; Thomas R Eisenreich; Junjie Chen; Ross A Dickins; Scott W Lowe; Andre Nussenzweig; Michel C Nussenzweig
Journal:  Nature       Date:  2006-01-08       Impact factor: 49.962

2.  Hepatitis C virus infection and lymphoma.

Authors:  Emmanuel Bachy; Caroline Besson; Felipe Suarez; Olivier Hermine
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-03-31       Impact factor: 2.576

Review 3.  Paradoxical role of Id proteins in regulating tumorigenic potential of lymphoid cells.

Authors:  Sumedha Roy; Yuan Zhuang
Journal:  Front Med       Date:  2018-07-24       Impact factor: 4.592

4.  AID-targeting and hypermutation of non-immunoglobulin genes does not correlate with proximity to immunoglobulin genes in germinal center B cells.

Authors:  Hillary Selle Gramlich; Tara Reisbig; David G Schatz
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

5.  Active RNAP pre-initiation sites are highly mutated by cytidine deaminases in yeast, with AID targeting small RNA genes.

Authors:  Benjamin J M Taylor; Yee Ling Wu; Cristina Rada
Journal:  Elife       Date:  2014-09-19       Impact factor: 8.140

6.  Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.

Authors:  Marius Rohde; Bettina R Bonn; Martin Zimmermann; Jonas Lange; Anja Möricke; Wolfram Klapper; Ilske Oschlies; Monika Szczepanowski; Inga Nagel; Martin Schrappe; Markus Loeffler; Reiner Siebert; Alfred Reiter; Birgit Burkhardt
Journal:  Haematologica       Date:  2017-02-16       Impact factor: 9.941

7.  CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein-Barr virus genes.

Authors:  Semjon Sidorov; Lara Fux; Katja Steiner; Samyo Bounlom; Sabrina Traxel; Tarik Azzi; Arbeneshe Berisha; Christoph Berger; Michele Bernasconi; Felix K Niggli; Yvonne Perner; Sugeshnee Pather; Werner Kempf; David Nadal; Simone Bürgler
Journal:  Cancer Immunol Immunother       Date:  2021-10-19       Impact factor: 6.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.